Implant Brand Tier List: What I Actually See in Turkish Clinic Treatment Plans
When a Turkish clinic quotes you for implants, the brand name appears somewhere in the treatment plan — sometimes prominently, sometimes buried, occasionally omitted entirely. That name is one of the most important variables in whether your implant succeeds long-term. Here is how to interpret it.
Why brand matters in implants specifically
Not all dental procedures have the same sensitivity to brand variation. A composite veneer using a mid-tier composite resin is not dramatically different from one using a premium resin. An implant is different because the outcome depends on a biological process — osseointegration — that unfolds over months or years, is influenced by the implant surface chemistry and geometry, and is affected by the quality of the prosthetic components assembled on top.
A clinic that uses a budget implant body but a well-made prosthetic is still using a budget implant body. The osseointegration failure rate at 5–10 years will reflect that decision, not the quality of the crown placed on top.
Tier 1 — Global benchmark
Straumann (Switzerland)
The gold standard in implantology. Over 40 years of peer-reviewed clinical documentation. Among the highest published success rates across bone types and patient profiles. Genuine Straumann-using clinics in Turkey charge noticeably more — that difference reflects real cost, not margin padding.
Nobel Biocare (Sweden)
The original Branemark implant system. Particularly well-documented for full-arch procedures including All-on-4. Widely used in Northern European markets and in higher-tier Turkish clinics.
Tier 2 — Solid regional brands
Osstem (South Korea)
The most commonly used implant brand in Turkish dental tourism. Growing clinical evidence base, particularly for straightforward single-unit and multiple-unit cases. Significantly cheaper than European premium brands while maintaining acceptable documented success rates.
Megagen (South Korea)
Known for the AnyRidge system which is designed for strong initial stability across varying bone densities. Increasingly common in Turkish clinics as an alternative to Osstem at similar cost points.
Tier 3 — Budget / unverified
Generic systems / white-label
These are implants sold under various names, often manufactured in Turkey, China, or Eastern Europe at a fraction of premium brand cost. Compatible implant components (compatible with Straumann or Nobel connections) are not the same as the original system. Independent long-term clinical data is limited or absent.
What to do with this information
When you receive a treatment plan, look for the implant brand name. If it is not listed, ask: "Which implant system are you using — brand name, product line, and country of manufacture?"
If the brand is in Tier 1 or Tier 2, ask for the specific product line (for Straumann: Bone Level, Tissue Level, BLX; for Osstem: GS, US, SS). These details allow verification against published clinical data and correct price benchmarking.
If the brand is unknown or unspecified, that is itself a finding. A clinic that cannot or will not name its implant brand is a clinic whose treatment plan cannot be properly evaluated. See the full dental implants guide for a complete list of questions to ask before committing to treatment.
Sources
- Pjetursson BE, et al. "A systematic review of the survival and complication rates of implant-supported fixed dental prostheses." Clinical Oral Implants Research, 2012.
- Moraschini V, et al. "Evaluation of survival and success rates of dental implants reported in longitudinal studies." Int J Oral Maxillofac Surg, 2015.
- Turkish Dental Association (TDA) — published fee schedules for clinical benchmarking, 2025–2026.
Dr. Hasan Taslidere
Dr. Taslidere is a dentist writing independently about dental treatment in Turkey for international patients. He has no financial relationship with any dental clinic and does not make referrals. Articles are checked against published clinical protocols and current Turkish market pricing.
About Dr. Taslidere →Commercial disclosure
Last reviewed on